Abstract-Iron oxide nanoparticles are currently under investigation as heating agents for hyperthermic treatment of tumors. Major determinants of effective heating include the biodistribution of magnetic materials, the minimum iron oxide loading required to achieve adequate heating, and practically achievable magnetic field strengths. These are inter-related criteria that ultimately determine the practicability of this approach to tumor treatment.
I. INTRODUCTION
AGNETIC nanoparticles, typically iron oxide (IONPs) in the form of Fe 3 O 4 with some type of bio-compatible coating such as starch or polyethylene glycol, are under investigation for tumor treatment, either by direct thermal damage or as an adjunct for other therapies. Key to success in this application is obtaining adequate heat in the target tissues. It is well understood that tumor vasculature has larger inter-endothelial gaps than most normal tissues, and that cells will transport IONPs from the extracellular space and cluster them into intracellular endosomes. However, owing to their small size and the overwhelming influence of local heat transfer, it is not clear that an adequate tumor load of magnetic nanoparticle (mNP) absorbing material can be accumulated to provide sufficient power absorption in practical magnetic fields. At present, the required tumoral mNP loading has not been determined quantitatively. Additionally, the range of practically achievable tumor loading has not been determined to date.
We undertook a series of in vivo experiments coupled with realistic Finite Element Method (FEM) numerical models studies to determine quantitative values that could be used in treatment planning and assessment.
II. METHODS

A. Experimental Studies
All animal experimentation was conducted under protocols approved by the Dartmouth IACUC in accordance with NIH guidelines.
Bilateral MTG-B tumors were implanted in the fore shoulders of six female C3H mice and allowed to develop for two weeks prior to treatment. Resulting tumor volumes ranged from 250 to 508 mm 3 at the time of treatment. The mouse fore shoulders were exposed to magnetic fields of approximately 34 kA/m (rms) at 160 kHz for heating times between 300 and 3,600 s (5 to 60 min.). Transient intratumoral, rectal and skin surface temperatures, as well as at several nearby points were recorded at 1s intervals using FISO optical probes 0.56 mm in diameter (FISO Inc., Quebec, Canada). The real-time skin surface temperature was also recorded with a FLIR Systems (Wilsonville,OR) thermal camera.
At the conclusion of the experiment the animals were euthanized, tumor tissues were excised and submitted for histologic evaluation. ), w = perfusion (s -1 ) and T = temperature (see Table I ). Q gen was adjusted until the experiment transient temperature record was closely approximated by the numerical model result. Volumetric heating in the iron oxide nanoparticles is dominated by Neél relaxation processes in the net magnetic spin moments at 160 kHz, denoted by the imaginary part of the magnetic permeability, " (Hy/m): The experiments were conducted at 162 kHz in a field strength of approximately 34 (kA/m rms) where the relative " ~ 3, so the maximum achievable volumetric power density in the iron oxide was approximately 9 x 10 9 (W/m 3 ). The magnetic material sizes range from hydrodynamic diameters of 60 to 120 nm and the Fe 3 O 4 occupies between 30 and 43% of the nanoparticle volume and only a very small fraction of the total tumor volume in each experiment.
B. Numerical Model Studies
The effective tumor loading of the injected nanoparticles cannot be determined by experimental means alone. The numerical model results were therefore used to estimate the tumor loading achieved in each of the experiments by comparing the uniform Q gen required to model the temperature record with the maximum achievable heating assuming 100% uptake in the tumor. The numerical models also included three thermal damage predictions, microvascular damage [2] , Dunning AT-1 cell death, as measured by histologic identification of apoptosis and necrosis [3] , and SN12 cell death as measured by propidium iodide uptake in damaged cells. [4] The damage model was calculated from Arrhenius kinetics:
where: C(t) = the remaining undamaged fraction,  = total experiment time (s), T = temperature (K), E a = the activation energy (J/mole), and A = the frequency factor (s -1
) for the damage process (Table II) . 
III. RESULTS
A. Transient Temperature Results
Experiment heating times ranged from 300 to 3600 (s) and maximum temperatures from 39 to 57 C. The experiment in Fig. 2 was the shortest in the ensemble, and achieved 51 C after 300 s of heating. Steady state had not been reached at the conclusion (Fig. 2a) . The numerical model (Fig. 2b) provided a reasonable match at Q gen = 1 x 10 6 (W/m 3 ). In the numerical model 600 s were allowed to reach the resting steady state before heating commenced. The particular tumor had ellipsiodal diameter dimensions of 11, 8.5 and 6.3 (height) mm (volume = 307 mm 3 ). The estimated maximum volume average power generation at 34 (kA/m) was 6.2 (MW/m 3 ). Consequently, we estimate an overall coupling efficiency of about 16% for this experiment: that is, the biodistribution realized was about 16% of the injected mass of iron oxide nanoparticles resident in the tumor at experiment time.
The top skin surface was a convective heat transfer boundary with convection coefficient h = 20 (W m -2 K -1
). The skin temperature of approximately 32 C at the end of the cooling phase agreed well with the experimental measurements. The temperature over the tumor was slightly higher than the surrounding skin due to the slightly higher metabolic heat (Table I) . The second phase, tumor heating, applied Q gen for the heating duration, and 200 s of cooling followed. The cooling transient temperature record matched the experiment with acceptable accuracy (Fig. 2) , indicating that the assumed heat transfer parameters were reasonable. As is the usual case, there are several differences between experiment and numerical model. For example, in Fig. 2 the temperature probe locations were estimated in the numerical model, and differed in either effective spatial location, or local biodistribution of mNPs. In all of the experiments, the magnetic field strength was kept constant. Two of the experiments showed evidence of vascular shutdown -a rapid temperature increase in the final stage of heatingthat was not observed in the numerical models in spite of coupling the microvascular damage process to the local perfusion. One example is shown in Fig. 3a , wherein the final maximum tumor temperature, 54 C, only occurred in the final few seconds of heating. The numerical model, Fig.  3b , did not have an analogous spike in the final result. Consequently, the thermal damage predictions for that model likely under estimate the in vivo result.
B. Thermal Damage and Cell Death Predictions
As may be surmised from the Arhenius damage model coefficients in Table II , the SN12 cells are much more thermally-robust than the AT-1 cells. The numerical model results (Table III) bear this out. The kinetic nature of the damage process development is also evident in the differences between microvascular damage and AT-1 cell death in experiments of differing heating durations. The apparent anomaly in the sequencing of the damage predictions in Table III is explained by the temperature spike in the higher temperature experiment contrasted with the absence of the spike in the associated numerical model, as previously mentioned * a temperature spike in this experiment (Fig. 3a) that was not successfully modeled (Fig. 3b) explains the anomalous sequence in damage predictions.
C. Estimates of Effective mNP Loading for the Experiments
FEM numerical model volume average power densities (Q gen ) were selected to provide the best match to the steady state final temperatures in order to provide an estimate of the effective power coupled to tumor tissue. The anomaly described in Fig. 3 resulted from this selection criterion.
The maximum power coupled to the tumor was estimated from the injected mass of iron oxide nanoparticles using Eq. (2) and an iron oxide density of 5242 (kg/m 3 ). The experiment series was designed around an assumed achievable average volume power density of approximately 6 (MW/m 3 ) with the exception of one experiment (see Table  IV ). The uniform volume power density required to simulate the experiment was used to estimate the probable overall effective power coupling efficiency, which ranged from less than 3 to approximately 20%. The results summarized in Table IV are listed in sequence of the maximum experimental temperature, the same sequence as Table III . The estimated effective tumor loading ranged from 0.5 to 1.5 g/mm 3 , or approximately 0.48 to 0.14 mg/g of tumor. There are several sources of uncertainty in the estimates due to: 1) variations in net tumor uptake, 2) spatial distribution of the mNPs in the tumor, 3) variations in the applied magnetic field due to positioning above the pancake coil. The overall estimate calculations assume: 1) a uniform mNP distribution, and 2) a uniform magnetic field strength for all experiments. Consequently, the overall coupling estimate below lumps all uncertainties into a net tumor uptake estimate. 
IV. CONCLUSION
The numerical model study has significantly improved our understanding of the experiment series and identified several important underlying phenomena.
The near-surface locations and small size of tumors in this experiment ensemble mean that surface heat transfer is a governing thermal phenomenon: most of the experiments resulted in steady-state temperature rises in which Q gen was balanced by local heat transfer. Successful heating of near surface tumors in the size range of 5 to 10 mm requires an effective tumor loading in excess of approximately 1 g/mm 3 (about 0.9 mg/g tumor). This is a significant treatment design parameter that establishes a useful treatment-planning criterion for mNP biodistribution. The results also reveal the differing nature of "success" as measured by thermal damage kinetics. That is, a single assessment criterion, such as CEM 43 , can be substantially misleading since it masks the differences among cell types and the kinetics of their responses to thermal insult. Realistic treatment planning must incorporate some analysis of the range of responses to be expected and the effect of varying kinetics.
